Submit Your Glaucoma Research to IJG
Join leading ophthalmology researchers advancing our understanding of glaucoma pathophysiology, molecular mechanisms, and disease progression
Complete your submission in 15 minutes
Two Convenient Ways to Submit
Choose the submission method that works best for your glaucoma research. Both options provide secure, efficient manuscript handling with full tracking capabilities.
ManuscriptZone Portal
Our comprehensive submission platform designed for complete manuscript management from submission through publication.
- Auto-save functionality protects your work
- Guided step-by-step submission workflow
- Real-time status tracking and updates
- Direct access to reviewer comments
- Revision submission and version control
- Secure document management
Best for: Authors who want complete visibility and control throughout the peer review process.
Submit via ManuscriptZoneQuick Submission Form
A streamlined alternative for straightforward manuscript submissions without account creation requirements.
- Simple, fast submission process
- No account registration needed
- Direct file upload capability
- Immediate submission confirmation
- Email-based status updates
Best for: Authors seeking a quick, simplified submission experience for standard manuscripts.
Use Quick Submission FormGlaucoma Research We Publish
International Journal of Glaucoma welcomes original research advancing our understanding of glaucoma pathophysiology, molecular mechanisms, biomarker discovery, and disease progression. We publish diverse manuscript types tailored to glaucoma research:
Original Research Articles
Novel investigations into glaucoma pathophysiology, molecular mechanisms, genetic factors, cellular pathways, and disease progression models.
Systematic Reviews & Meta-Analyses
Comprehensive syntheses of glaucoma research evidence, molecular pathway analyses, and biomarker validation studies.
Methods & Protocols
Novel experimental techniques, disease modeling approaches, biomarker detection methods, and molecular analysis protocols for glaucoma research.
Short Communications
Preliminary findings, novel observations, or significant technical advances in glaucoma pathophysiology research requiring rapid dissemination.
Case Reports
Unique clinical presentations revealing novel pathophysiological insights, rare genetic variants, or unusual disease mechanisms in glaucoma.
Review Articles
Comprehensive overviews of glaucoma pathophysiology topics, molecular mechanisms, emerging biomarkers, and disease progression theories.
Specialized Focus: We particularly welcome research on molecular mechanisms of optic nerve degeneration, retinal ganglion cell death pathways, aqueous humor dynamics, intraocular pressure regulation, genetic risk factors, neuroprotective mechanisms, and novel biomarker discovery in glaucoma pathophysiology.
Pre-Submission Checklist
Ensure your glaucoma research manuscript is ready for submission by verifying these essential components:
Word or LaTeX format, properly formatted with all sections
High-resolution images (300 DPI minimum), TIFF or EPS format preferred
IRB/ethics committee approval for human/animal studies
All authors have reviewed and approved the manuscript
Declaration of financial or non-financial conflicts
Highlighting significance and novelty of your glaucoma research
Transparent Peer Review Timeline
We believe in transparency. Here's exactly what happens after you submit your glaucoma research to IJG:
Submission Received
Your manuscript enters our system and undergoes initial completeness check and plagiarism screening using iThenticate.
Day 0Editor Screening
An editor with expertise in glaucoma pathophysiology reviews your manuscript for scope, quality, and adherence to guidelines.
Days 1-3Peer Review
Expert reviewers specializing in glaucoma research evaluate your methodology, results, and conclusions. We select reviewers based on their publication record in glaucoma pathophysiology.
Days 4-21Editorial Decision
Based on reviewer feedback, the editor makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed reviewer comments.
Day 28Revision & Re-review
If revisions are requested, you submit your revised manuscript with a point-by-point response. Reviewers assess your revisions.
Days 29-42Acceptance & Production
Upon acceptance, your manuscript enters production for copyediting, typesetting, and final formatting.
Days 43-52Publication
Your glaucoma research is published online with immediate open access, indexed in and other major databases.
Day 60Average Timeline: From submission to publication in approximately 60 days. Fast-track review available for breakthrough glaucoma research findings.
Why Glaucoma Researchers Choose IJG
Indexed Globally
Google Scholar, and specialized ophthalmology databases
Expert Reviewers
Peer review by leading glaucoma researchers and pathophysiology specialists
Fast Decisions
Average 21 days to first decision with transparent timeline tracking
Open Access
Immediate worldwide visibility with no access barriers for readers
COPE
Committed to highest ethical publishing standards and best practices
APC Waivers
Financial support available for eligible authors from developing countries
What Makes Your Glaucoma Research Suitable for IJG?
We Welcome Research On:
- Molecular mechanisms of retinal ganglion cell death and optic nerve degeneration
- Genetic and epigenetic factors in glaucoma susceptibility and progression
- Cellular pathways involved in intraocular pressure regulation and aqueous humor dynamics
- Biomarker discovery for early detection and disease monitoring
- Animal models and in vitro systems for glaucoma pathophysiology research
- Neuroinflammation and immune mechanisms in glaucoma progression
- Mitochondrial dysfunction and oxidative stress in glaucomatous neurodegeneration
- Extracellular matrix remodeling in trabecular meshwork and optic nerve head
- Neuroprotective mechanisms and potential therapeutic targets
- Vascular factors and blood flow dysregulation in glaucoma
- Proteomics and metabolomics approaches to understanding glaucoma pathogenesis
- Stem cell biology and regenerative medicine approaches for glaucoma
Interdisciplinary Research Welcome: We encourage submissions that integrate molecular biology, genetics, biochemistry, cell biology, neuroscience, and computational modeling to advance understanding of glaucoma pathophysiology.
Manuscript Preparation Guidelines
Structure Your Glaucoma Research Manuscript:
Title: Concise and descriptive, highlighting the key finding or mechanism investigated (maximum 150 characters).
Abstract: Structured format (Background, Methods, Results, Conclusions) summarizing your glaucoma research in 250-300 words. Clearly state the pathophysiological mechanism or biomarker investigated.
Keywords: 5-8 terms including specific glaucoma-related terminology (e.g., "retinal ganglion cell apoptosis," "trabecular meshwork dysfunction," "optic nerve head biomechanics").
Introduction: Establish the pathophysiological context, current understanding of mechanisms, knowledge gaps, and specific research objectives.
Methods: Detailed description of experimental models (animal models, cell culture systems), molecular techniques, statistical analyses, and validation approaches. Include ethics approval information.
Results: Present findings logically with appropriate figures showing molecular data, pathway analyses, or biomarker validation. Use high-quality images of immunohistochemistry, Western blots, or microscopy.
Discussion: Interpret findings in context of glaucoma pathophysiology, compare with existing literature, discuss mechanistic implications, acknowledge limitations, and suggest future research directions.
References: Vancouver style citation. Include key glaucoma pathophysiology papers and recent advances in the field.
Ready to Submit Your Glaucoma Research?
Join the growing community of researchers advancing our understanding of glaucoma pathophysiology through rigorous, innovative science.
Begin Submission ProcessQuestions about the submission process? Contact our editorial team at [email protected]
